A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly

Toxicology

Volumn 241, Issue 1-2, 2007, Pages 19-32

  Schümann, Klaus ^a   Szegner, Bernadett ^a   Kohler, Birgit ^a   Pfaffl, Michael W ^a   Ettle, Thomas ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Iron distribution; Kinetics; Mouse; Residual blood

Indexed keywords

IRON 59; HEMOGLOBIN; IRON; NONHEME IRON PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BLOOD VOLUME; CONTROLLED STUDY; DRUG TISSUE LEVEL; ERYTHROPOIESIS; HOMEOSTASIS; IRON DEFICIENCY; IRON METABOLISM; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; BLOOD FLOW; BODY WEIGHT; BONE MARROW; C57BL MOUSE; ERYTHROCYTE; METABOLISM; NUTRITIONAL STATUS; ORGAN SIZE; PHYSIOLOGY; TISSUE DISTRIBUTION;

MURINAE; MUS;

ANIMALS; BLOOD VOLUME; BODY WEIGHT; BONE MARROW; ERYTHROCYTES; HEMOGLOBINS; IRON; IRON RADIOISOTOPES; MALE; MICE; MICE, INBRED C57BL; NONHEME IRON PROTEINS; NUTRITIONAL STATUS; ORGAN SIZE; REGIONAL BLOOD FLOW; TISSUE DISTRIBUTION;

EID: 35348955955     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.08.082     Document Type: Article

References (46)

1. Bahram S., Gilfillan S., Kühn L.C., Moret R., Schulze J., Lebeau A., and Schümann K. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. PNAS 96 (1999) 13312-13317
2. Beard J.L. Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr. 131 (2001) 568S-580S
3. Berlin N.I., Huff R.L., van Dyke D.C., and Hennessy T.G. Proc. Soc. Exp. Bio. Med. 71 (1949) 179
4. Bothwell T.H., Charlton R.W., Cook J.D., and Finch C.A. Iron metabolism in man. Internal Iron Kinetics (1979), Blackwell Scientific Publications, Oxford pp. 327-349, Chapter 15
5. Casanueva E., Viteri F.E., Mares-Galindo M., Meza-Camacho C., Loria A., Schnaas L., and Valdes-Ramos R. Weekly iron as a safe alternative to daily supplementation for nonanemic pregnant women. Arch. Med. Res. 37 (2006) 674-682
6. Chen H., Su T., Attieh Z.K., Fox T.C., McKie A.T., Anderson G.J., and Vulpe C.D. Systemic regulation of hephaestin and Ireg 1 revealed in studies of genetic and nutritional iron deficiency. Blood 102 (2003) 1893-1899
7. Cheng Y., Zak O., Aisen P., Harrison S.C., and Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 116 (2004) 565-576
8. Conrade M.E., Weintraub L.R., and Crosby W.H. The role of the intestine in iron kinetics. J. Clin. Invest. 43 (1964) 963-974
9. Dupic F., Fruchon S., Bensaid M., Borot N., Radosavljevic M., Loreal O., Brissot P., Gilfillan S., Bahram S., Coppin H., and Roth M.-P. Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology 122 (2002) 745-751
10. Epzstejn S., Glickstein H., Picard U., Slotki I.N., Breuer W., Beaumont C., and Cabantchik Z.I. H-ferritin subunit over-expression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94 (1999) 3593-3603
11. 131) volumes of rats determined by liquid nitrogen freezing. Circ. Res. 4 (1956) 419-424
12. Fergelot P., Ropert-Bouchet M., Abgueguen, Orhant M., Radosavljevic M., Grimber G., Jouan H., Le Gall J.-Y., Mosser J., Gilfillan S., and Bahram S. Iron overload in mice expressing HFE exclusively in the intestinal villi provides evidence that HFE regulates a functional cross-talk between crypt and villi enterocytes. Blood Cells Mol. Dis. 28 (2002) 348-360
13. Ferguson C.F., Wareing M., Ward D.T., Green R., Smith C.P., and Riccardie D. Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am. J. Physiol. 280 (2001) F803-F814
14. Fleming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D., and Andrews N.C. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. PNAS 95 (1998) 1148-1153
15. Fleming R.E., Holden C.C., Tomatsu S., Waheed A., Brunt E.M., Britton R.S., Bacon B.R., Roopenian D.C., and Sly W.S. Mouse strain differences determined severity of iron accumulation in HFE knockout mode of hereditary hemochromatosis. PNAS 98 (2001) 2707-2711
16. Frazer D.M., Inglis H.R., Wilkins S.J., Millard K.N., Steele T.M., McLaren G.D., McKie A.T., Vulpe C.D., and Anderson G.J. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 53 (2004) 1509-1515
17. Frazer D.M., Wikins S.J., Becker E.M., Vulpe C.D., McKie A.T., Trinder D., and Anderson G.J. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123 (2002) 835-844
18. Galy B., Ferring D., Minana B., Bell O., Janser H.G., Muckenthaler M., Schümann K., and Hentze M.W. Altered body iron distribution and microcytosis in mice deficient in Iron-Regulatory Protein 2 (IRP2). Blood 106 (2005) 2580-2589
19. Glader B. Anemias of inadequate production, iron-deficiency anemia. In: Behrmann R.E., Klingman R.M., and Jenson H.B. (Eds). Nelson Textbook of Pediatrics. 17th ed. (2004), Sounder, Philadelphia pp. 1606-1617, Chapter 447
20. Grabill C., Silva A.C., Smith S.S., Koretsky A.P., and Rouault T.A. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res. 971 (2003) 95-106
21. Gregersen M.I., and Rawson R.A. Blood volume. Physiol. Rev. 39 (1956) 307-342
22. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
23. 59Fe distribution and expression in rats at low doses. Toxicology 150 (2000) 69-82
24. Iannotti L.L., Tielsch J.M., Black M.M., and Black R.E. Iron supplementation in early childhood: health benefits and risks. Am. J. Clin. Nutr. 84 (2006) 1261-1276
25. Jasinski M., Pantazopoulos P., Rother P., van Rooijen N., Song W.-C., Molina H., and Bessler M. A novel mechanism of complement-independent clearance of red cells, deficient in glycosyl-phosphatidylinositol-linked proteins. Blood 103 (2004) 2827-2834
26. Kakhlon O., Gruenbaum Y., and Cabanchik Z.I. Repression of the heavy ferritin chain increases the labile iron pool in human K562 cells. Biochem. J. 356 (2001) 311-316
27. Knutson M.D., Oukka M., Koss L.M., Aydemier F., and Wessling-REsnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. PNAS 102 (2005) 1324-1328
28. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1906-1910
29. Levy J.E., Jin O., Fujiwara Y., Kuo F., and Andrews N.C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21 (1999) 396-399
30. Lynch S.R. Iron. In: Solomons N.W., and Rosenberg U.H. (Eds). Absorption and Malabsorption of Mineral Nutrients (1984), Alan R. Liss Inc., New York 89-124
31. 51-labelled red blood cells. Am. J. Physiol. 196 (1959) 169-172
32. Nemeth E., Rivery S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 (2004) 1271-1276
33. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
34. Nicolas G., Bennoun M., Devaux I., Beaummont C., Grandchamp B., Kahn A., and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. PNAS 98 (2001) 8780-8785
35. Noyes W.D., Bothwell T.H., and Finch C.A. The role of the reticuloendothelial cell in iron metabolism. Brit. J. Haematol. 6 (1960) 43-55
36. Papanikolaou G., and Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202 (2005) 199-211
37. Puntarulo S. Iron, oxidative stress and human health. Mol. Aspects Med. 26 (2005) 299-312
38. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., Dhingra U., Kabole I., Deb S., Othman M.K., and Kabole F.M. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367 (2006) 133-143
39. Schümann K., Elsenhans B., Hunder G., Strugala G., and Forth W. Increase of intestinal iron absorption in growing rats and mice after 8 days of iron-deficient feeding. Z Versuchstierkd. 32 (1989) 261-267
40. Schümann K., Kreppel K., and Elsenhans B. Determination of residual erythrocytes in rat tissue homogenates using commercially available anti-red blood cess. sera. J. Pharm. Methods 21 (1989) 281-285
41. Schümann K., Kroll S., Weiss G., Frank J., Biesalski H.K., Daniel H., Friel J., and Solomons N.W. Monitoring of haematological, inflammatory and oxidative reactions of acute oral iron exposure in human volunteers: Preliminary screening for selection of potentially-responsive biomarkers. Toxicology 212 (2005) 10-23
42. Schümann K., Moret R., Künzle H., and Kühn L.C. Iron regulatory protein as an endogenous sensor of iron in rat intestinal mucosa. Eur. J. Biochem. 260 (1999) 362-372
43. Toost F.J., Saris W.H.M., Haenen G.R.M.M., Bast A., and Brummer R.-J.M. New method to study oxidative damage and antioxidants in the human small bowel effects of iron application. Am. J. Gastrointest. Liver Physiol. 285 (2003) G354-G359
44. Torrance J.D., and Bothwell T.H. A simple technique for measuring iron concentrations in formalinised liver samples. S. Afr. J. Med. Sci. 33 (1968) 9-11
45. Trenor III C.C., Campagna D.R., Sellers V.M., Andrews N.C., and Fleming M.D. The molecular defect in hypotransferrinemic mice. Blood 96 (2000) 1113-1118
46. World Health Organisation, 2002. Reducing risks, promoting healthy life. The World Health Report 2002. Geneva, Switzerland.